10-K
Annual Report
Autonomix Medical, Inc.
AMIX
NASDAQ
CIK: 1617867
File #: 001-41940
Balance Sheet
28 line items · 2 periods
XBRL
| Item | Mar 31, 2025 | Mar 31, 2024 |
|---|---|---|
Current assets: | ||
Cash and cash equivalents | 9,136,000 | 8,608,000 |
Other current assets | 473,000 | 783,000 |
Total current assets | 9,609,000 | 9,391,000 |
Long-term assets: | ||
Fixed assets, net | 21,000 | 16,000 |
Deferred offering costs | 176,000 | 0 |
Total long-term assets | 197,000 | 16,000 |
Total Assets | 9,806,000 | 9,407,000 |
Current liabilities: | ||
Accounts payable | 676,000 | 492,000 |
Accrued expenses | 1,031,000 | 285,000 |
Total current liabilities | 1,707,000 | 777,000 |
Long-term liabilities: | ||
Long term debt - convertible notes, net of unamortized debt discount | 0 | 1,002,000 |
The Notes - Convertible Debt | 0 | 1,002,000 |
Total long-term liabilities | 0 | 1,002,000 |
Total Liabilities | 1,707,000 | 1,779,000 |
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2025 and March 31, 2024, respectively. | 0 | 0 |
Common stock, $0.001 par value, 500,000,000 shares authorized, 2,497,033 and 942,575 shares issued and outstanding as of March 31, 2025 and March 31, 2024, respectively. | 2,000 | 1,000 |
Additional paid-in capital | 58,476,000 | 46,596,000 |
Accumulated deficit | (50,379,000) | (38,969,000) |
Total Stockholders' Equity | 8,099,000 | 7,628,000 |
Common Stock | 2,000 | 1,000 |
Additional Paid-in Capital | 58,476,000 | 46,596,000 |
Retained Earnings | (50,379,000) | (38,969,000) |
Total Liabilities and Stockholders' Equity | 9,806,000 | 9,407,000 |